Naproxcinod: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, Nitronaproxen, NO-Naproxen

ISSN： 1174-5886

Source： Drugs in R&D, Vol.8, Iss.4, 2007-01, pp. : 255-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitronaproxen: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, NO-Naproxen

By Adis International Limited

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 262-266

Adis International

Access to resources Recommend Favorite

The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers

By Jonzon Bror

Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. : 437-444

VSP

Access to resources Recommend Favorite

Naproxcinod beats naproxen in hypertensive OA patients

Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: A randomized, double‐blind, parallel‐group, multicenter study

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3635-3644

John Wiley & Sons Inc

Access to resources Recommend Favorite

Naproxen: Hepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite